IOVA
Iovance Biotherapeutics, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3,
"returned": 3,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "ae1f1a87-40b3-4850-a6f6-a017a96e58a8",
"title": "Iovance Biotherapeutics, Inc. : Truist Securities reste à l'achat",
"description": "Truist Securities est positif et recommande le titre à l'achat. L'objectif de cours est abaissé de 26 USD à 25 USD.",
"keywords": "Bourse",
"snippet": "Iovance Biotherapeutics, Inc. est une société biopharmaceutique au stade clinique. La société développe et fournit des thérapies à base de lymphocytes in...",
"url": "https://www.zonebourse.com/cours/action/IOVANCE-BIOTHERAPEUTICS-I-36879287/actualite/Iovance-Biotherapeutics-Inc-Truist-Securities-reste-a-l-achat-46709424/",
"image_url": "https://www.zonebourse.com/images/twitter_ZB_fdnoir.png",
"language": "fr",
"published_at": "2024-05-13T19:00:13.000000Z",
"source": "zonebourse.com",
"relevance_score": null,
"entities": [
{
"symbol": "IOVA",
"name": "Iovance Biotherapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 174.94655,
"sentiment_score": null,
"highlights": [
{
"highlight": "<em>Iovance</em> <em>Biotherapeutics</em>, <em>Inc</em>. est une société biopharmaceutique au stade clinique. La société développe et fournit des thérapies à base de lymphocytes infiltrant les tumeurs (TIL) pour les patients atteints de cancers à tumeurs solides.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Iovance</em> <em>Biotherapeutics</em>, <em>Inc</em>. : Truist Securities reste à l'achat",
"sentiment": 0.5267,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "90d742b2-6205-4c5f-ab7f-12e1bccebcfb",
"title": "Looking At Iovance Biotherapeutics's Recent Unusual Options Activity - Iovance Biotherapeutics (NASDAQ:IOVA)",
"description": "",
"keywords": "",
"snippet": "Loading... Loading...\n\nInvestors with a lot of money to spend have taken a bullish stance on Iovance Biotherapeutics IOVA.\n\nAnd retail traders should know.\n\nWe ...",
"url": "https://www.benzinga.com/insights/options/24/05/38797389/looking-at-iovance-biotherapeuticss-recent-unusual-options-activity",
"image_url": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-05-13T17:45:48.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "IOVA",
"name": "Iovance Biotherapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 133.83823,
"sentiment_score": 0.129218,
"highlights": [
{
"highlight": "Investors with a lot of money to spend have taken a bullish stance on <em>Iovance</em> <em>Biotherapeutics</em> IOVA.\n\nAnd retail traders should know.\n\nWe noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.\n\nWhether these are institutions or just wealthy individuals, we don't know.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Today, Benzinga's options scanner spotted 8 options trades for <em>Iovance</em> <em>Biotherapeutics</em>.\n\nThis isn't normal.\n\nThe overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.\n\nOut of all of the options we uncovered, there was 1 put, for a total amount of $44,179, and 7, calls, for a total amount of $403,560.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Projected Price Targets\n\nTaking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $6.0 to $15.0 for <em>Iovance</em> <em>Biotherapeutics</em> over the last 3 months.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Volume & Open Interest Development\n\nIn today's trading context, the average open interest for options of <em>Iovance</em> <em>Biotherapeutics</em> stands at 3011.6, with a total volume reaching 5,308.00.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in <em>Iovance</em> <em>Biotherapeutics</em>, situated within the strike price corridor from $6.0 to $15.0, throughout the last 30 days.\n\nLoading... Loading...",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Iovance</em> <em>Biotherapeutics</em> Option Volume And Open Interest Over Last 30 Days\n\nLargest Options Trades Observed:\n\nSymbol PUT/CALL Trade Type Sentiment Exp.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Biotherapeutics</em>\n\n<em>Iovance</em> <em>Biotherapeutics</em> <em>Inc</em> is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient.",
"sentiment": -0.8689,
"highlighted_in": "main_text"
},
{
"highlight": "In light of the recent options history for <em>Iovance</em> <em>Biotherapeutics</em>, it's now appropriate to focus on the company itself. We aim to explore its current performance.\n\nCurrent Position of <em>Iovance</em> <em>Biotherapeutics</em>\n\nTrading volume stands at 5,705,180, with IOVA's price down by -2.72%, positioned at $10.67.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "What The Experts Say On <em>Iovance</em> <em>Biotherapeutics</em>\n\nA total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $32.0.\n\nReflecting concerns, an analyst from HC Wainwright & Co. lowers its rating to Buy with a new price target of $32.",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Keep up with the latest options trades for <em>Iovance</em> <em>Biotherapeutics</em> with Benzinga Pro for real-time alerts.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Looking At Iovance Biotherapeutics's Recent Unusual Options Activity - <em>Iovance</em> <em>Biotherapeutics</em> (<em>NASDAQ:IOVA</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5cfcfbfa-cb8f-4cf6-99e8-36150ff79327",
"title": "Iovance Biotherapeutics' Amtagvi: Innovative Therapy, Financial Strain (Downgrade) (IOVA)",
"description": "Iovance's launched a new TIL therapy Amtagvi, but with modest Q1 revenue amidst substantial operational costs. Learn why I recommend hold rating for IOVA stock.",
"keywords": "",
"snippet": "courtneyk/E+ via Getty Images\n\nEvaluating Iovance Amidst Amtagvi's Launch and Financial Pressures\n\nIovance Biotherapeutics' (NASDAQ:IOVA) stock continues its ro...",
"url": "https://seekingalpha.com/article/4692766-iovance-biotherapeutics-amtagvi-innovative-therapy-financial-strain-rating-downgrade",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1224254306/image_1224254306.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-05-13T15:06:56.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "IOVA",
"name": "Iovance Biotherapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.73395,
"sentiment_score": 0.04185,
"highlights": [
{
"highlight": "courtneyk/E+ via Getty Images\n\nEvaluating Iovance Amidst Amtagvi's Launch and Financial Pressures\n\n<em>Iovance</em> <em>Biotherapeutics</em>' (<em>NASDAQ:IOVA</em>) stock continues its rollercoaster ride. Its stock traded down 18% on Friday, the day after it reported Q1 earnings.",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Iovance</em> <em>Biotherapeutics</em>' Amtagvi: Innovative Therapy, Financial Strain (Downgrade) (IOVA)",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "IOVA",
"total_documents": 3,
"sentiment_avg": 0.0855339989066124
}
]
}
Other details
Exchange
- NASDAQ Stock Exchange
- equity
- Healthcare
- us